{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:28:35Z","timestamp":1778884115288,"version":"3.51.4"},"reference-count":220,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T00:00:00Z","timestamp":1334275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The complex hide-and-seek game between HIV-1 and the host immune system has impaired the development of an efficient vaccine. In addition, the high variability of the virus impedes the long-term control of viral replication by small antiviral drugs. For more than 20 years, phage display technology has been intensively used in the field of HIV-1 to explore the epitope landscape recognized by monoclonal and polyclonal HIV-1-specific antibodies, thereby providing precious data about immunodominant and neutralizing epitopes. In parallel, biopanning experiments with various combinatorial or antibody fragment libraries were conducted on viral targets as well as host receptors to identify HIV-1 inhibitors. Besides these applications, phage display technology has been applied to characterize the enzymatic specificity of the HIV-1 protease. Phage particles also represent valuable alternative carriers displaying various HIV-1 antigens to the immune system and eliciting antiviral responses. This review presents and summarizes the different studies conducted with regard to the nature of phage libraries, target display mode and biopanning procedures.<\/jats:p>","DOI":"10.3390\/ijms13044727","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T11:38:42Z","timestamp":1334317122000},"page":"4727-4794","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Phages and HIV-1: From Display to Interplay"],"prefix":"10.3390","volume":"13","author":[{"given":"Sylvie","family":"Delhalle","sequence":"first","affiliation":[{"name":"Laboratory of Retrovirology, CRP-Sante, 84, Val Fleuri, L-1526 Luxembourg, Luxembourg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Schmit","sequence":"additional","affiliation":[{"name":"Laboratory of Retrovirology, CRP-Sante, 84, Val Fleuri, L-1526 Luxembourg, Luxembourg"},{"name":"Service National des Maladies Infectieuses, Centre Hospitalier Luxembourg, 4, rue E. Barbl\u00e9, L-1210 Luxembourg, Luxembourg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Chevign\u00e9","sequence":"additional","affiliation":[{"name":"Laboratory of Retrovirology, CRP-Sante, 84, Val Fleuri, L-1526 Luxembourg, Luxembourg"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM198112103052401","article-title":"Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency","volume":"305","author":"Gottlieb","year":"1981","journal-title":"N. Engl. J. Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a t-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Chermann","year":"1983","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.antiviral.2009.07.016","article-title":"Running a tightrope: Regulatory challenges in the development of antiretrovirals","volume":"85","author":"Naeger","year":"2010","journal-title":"Antiviral Res"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"Kilby","year":"1998","journal-title":"Nat. Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (uk-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1021\/jm060854f","article-title":"4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species","volume":"49","author":"Summa","year":"2006","journal-title":"J. Med. Chem"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/aid.2007.0236","article-title":"Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided haart","volume":"24","author":"Tozzi","year":"2008","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1099\/0022-1317-82-8-1807","article-title":"An overview of the determinants of CCR5 and CXCR4 co-receptor function","volume":"82","author":"Dragic","year":"2001","journal-title":"J. Gen. Virol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/JVI.02046-08","article-title":"The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions","volume":"83","author":"Pantophlet","year":"2009","journal-title":"J. Virol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/JVI.01328-08","article-title":"Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers","volume":"83","author":"Mahalanabis","year":"2009","journal-title":"J. Virol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a007039","DOI":"10.1101\/cshperspect.a007039","article-title":"The antibody response against HIV-1","volume":"2","author":"Overbaugh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/molecules16043089","article-title":"Lambda-display: A powerful tool for antigen discovery","volume":"16","author":"Beghetto","year":"2011","journal-title":"Molecules"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0378-1119(88)90495-7","article-title":"Antibody-selectable filamentous fd phage vectors: Affinity purification of target genes","volume":"73","author":"Parmley","year":"1988","journal-title":"Gene"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1099\/vir.0.027102-0","article-title":"Human immunodeficiency virus type 1 long-term non-progressors: The viral, genetic and immunological basis for disease non-progression","volume":"92","author":"Poropatich","year":"2011","journal-title":"J. Gen. Virol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1073\/pnas.88.8.3238","article-title":"Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein","volume":"88","author":"Gorny","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1006\/viro.1993.1179","article-title":"Identification of HIV vaccine candidate peptides by screening random phage epitope libraries","volume":"193","author":"Keller","year":"1993","journal-title":"Virology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1089\/aid.1997.13.1549","article-title":"Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries","volume":"13","author":"Boots","year":"1997","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0378-1119(93)90252-X","article-title":"Defining critical residues in the epitope for a HIV-neutralizing monoclonal antibody using phage display and peptide array technologies","volume":"137","author":"Jellis","year":"1993","journal-title":"Gene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/jvi.69.1.122-130.1995","article-title":"A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade b","volume":"69","author":"Moore","year":"1995","journal-title":"J. Virol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0378-1119(95)00658-3","article-title":"Epitope mapping of anti-HIV and anti-HCV monoclonal antibodies and characterization of epitope mimics using a filamentous phage peptide library","volume":"166","author":"Grihalde","year":"1995","journal-title":"Gene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/eji.1830260734","article-title":"Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1","volume":"26","author":"Laisney","year":"1996","journal-title":"Eur. J. Immunol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.91.8.3348","article-title":"Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by iam-41-2f5, an anti-gp41 human monoclonal antibody","volume":"91","author":"Conley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jmb.2004.02.051","article-title":"Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope","volume":"338","author":"Menendez","year":"2004","journal-title":"J. Mol. Biol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2010.12.008","article-title":"Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mab 2f5","volume":"136","author":"Gazarian","year":"2011","journal-title":"Immunol. Lett"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1096\/fasebj.11.2.9039957","article-title":"Helical epitopes determined by low-stringency antibody screening of a combinatorial peptide library","volume":"11","author":"Stern","year":"1997","journal-title":"FASEB J"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00126334-200210010-00004","article-title":"Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody","volume":"31","author":"Cao","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1128\/JVI.75.14.6692-6699.2001","article-title":"Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12","volume":"75","author":"Zwick","year":"2001","journal-title":"J. Virol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/jmbi.1996.0284","article-title":"Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage","volume":"258","author":"Bonnycastle","year":"1996","journal-title":"J. Mol. Biol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/aid.2005.21.82","article-title":"Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes","volume":"21","author":"Dorgham","year":"2005","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jmb.2003.09.002","article-title":"The mapping and reconstitution of a conformational discontinuous b-cell epitope of HIV-1","volume":"334","author":"Denisov","year":"2003","journal-title":"J. Mol. Biol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1089\/aid.2007.0027","article-title":"Peptides selected from a phage display library with an HIV-neutralizing antibody elicit antibodies to HIV gp120 in rabbits, but not to the same epitope","volume":"23","author":"Wilkinson","year":"2007","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1399-3011.1999.00082.x","article-title":"Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120","volume":"54","author":"Ferrer","year":"1999","journal-title":"J. Pept. Res"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1096\/fj.07-8983com","article-title":"A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120","volume":"22","author":"Menendez","year":"2008","journal-title":"FASEB J"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1073\/pnas.85.9.3198","article-title":"Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120","volume":"85","author":"Rusche","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1073\/pnas.86.17.6768","article-title":"Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein","volume":"86","author":"Javaherian","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1073\/pnas.87.21.8597","article-title":"Human monoclonal antibody that recognizes the v3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain","volume":"87","author":"Scott","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/jvi.67.11.6642-6647.1993","article-title":"A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1","volume":"67","author":"Muster","year":"1993","journal-title":"J. Virol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/aid.1996.12.901","article-title":"Humoral immune response to immunocomplexed HIV envelope glycoprotein 120","volume":"12","author":"Denisova","year":"1996","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1073\/pnas.88.22.10134","article-title":"A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals","volume":"88","author":"Burton","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1073\/pnas.89.19.9339","article-title":"Recombinant human fab fragments neutralize human type 1 immunodeficiency virus in vitro","volume":"89","author":"Barbas","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1096\/fj.05-5509rev","article-title":"Computational prediction of the cross-reactive neutralizing epitope corresponding to the [corrected] monclonal [corrected] antibody b12 specific for HIV-1 gp120","volume":"20","author":"Bublil","year":"2006","journal-title":"FASEB J"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding","volume":"280","author":"Rizzuto","year":"1998","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1128\/jvi.68.12.8350-8364.1994","article-title":"Exploration of antigenic variation in gp120 from clades a through f of human immunodeficiency virus type 1 by using monoclonal antibodies","volume":"68","author":"Moore","year":"1994","journal-title":"J. Virol"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/jvi.67.7.3978-3988.1993","article-title":"Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding","volume":"67","author":"Thali","year":"1993","journal-title":"J. Virol"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","article-title":"The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of \u03b11\u21922 mannose residues on the outer face of gp120","volume":"76","author":"Scanlan","year":"2002","journal-title":"J. Virol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/jvi.70.2.1100-1108.1996","article-title":"Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1","volume":"70","author":"Trkola","year":"1996","journal-title":"J. Virol"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","article-title":"The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120","volume":"76","author":"Sanders","year":"2002","journal-title":"J. Virol"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.4049\/jimmunol.162.10.6155","article-title":"Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera","volume":"162","author":"Scala","year":"1999","journal-title":"J. Immunol"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm1101-1225","article-title":"Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes","volume":"7","author":"Chen","year":"2001","journal-title":"Nat. Med"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1096\/fj.00-0898com","article-title":"Dissection of the humoral immune response toward an immunodominant epitope of HIV: A model for the analysis of antibody diversity in HIV+ individuals","volume":"15","author":"Smelyanski","year":"2001","journal-title":"FASEB J"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.mimet.2006.08.001","article-title":"Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope","volume":"68","author":"Gazarian","year":"2007","journal-title":"J. Microbiol. Methods"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/eji.200636560","article-title":"Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma","volume":"37","author":"Humbert","year":"2007","journal-title":"Eur. J. Immunol"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Humbert, M., Rasmussen, R.A., Ong, H., Kaiser, F.M., Hu, S.L., and Ruprecht, R.M. (2008). Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing. PLoS One, 3.","DOI":"10.1371\/journal.pone.0003937"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Dieltjens, T., Heyndrickx, L., Willems, B., Gray, E., Van Nieuwenhove, L., Grupping, K., Vanham, G., and Janssens, W (2009). Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies. Retrovirology, 6.","DOI":"10.1186\/1742-4690-6-113"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jviromet.2010.07.004","article-title":"Unravelling the antigenic landscape of the HIV-1 subtype a envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries","volume":"169","author":"Dieltjens","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1081\/PB-100103383","article-title":"Mapping of HIV-1 gag epitopes recognized by polyclonal antibodies using gene-fragment phage display system","volume":"31","author":"Gupta","year":"2001","journal-title":"Prep. Biochem. Biotechnol"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic. Acids Res"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jcc.20229","article-title":"3d-epitope-explorer (3dex): Localization of conformational epitopes within three-dimensional structures of proteins","volume":"26","author":"Schreiber","year":"2005","journal-title":"J. Comput. Chem"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.00558-06","article-title":"Molecularly cloned SHIV-1157IPD3N4: A highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade c env","volume":"80","author":"Song","year":"2006","journal-title":"J. Virol"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2004.11.025","article-title":"Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5","volume":"299","author":"Konigs","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1162::AID-IMMU1162>3.0.CO;2-L","article-title":"Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: Implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120","volume":"30","author":"Konigs","year":"2000","journal-title":"Eur. J. Immunol"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0161-5890(99)00132-7","article-title":"Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1\u03b1-binding activity","volume":"36","author":"Meta","year":"1999","journal-title":"Mol. Immunol"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1128\/JVI.79.11.6791-6800.2005","article-title":"Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity","volume":"79","author":"Khurana","year":"2005","journal-title":"J. Virol"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/1521-4141(200101)31:1<57::AID-IMMU57>3.0.CO;2-9","article-title":"Identification of a LFA-1 region involved in the HIV-1-induced syncytia formation through phage-display technology","volume":"31","author":"Poloni","year":"2001","journal-title":"Eur. J. Immunol"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.186.8.1373","article-title":"Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding","volume":"186","author":"Wu","year":"1997","journal-title":"J. Exp. Med"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.185.9.1681","article-title":"CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro","volume":"185","author":"Wu","year":"1997","journal-title":"J. Exp. Med"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1084\/jem.173.2.511","article-title":"Human immunodeficiency virus (HIV) infection in CD4+ t lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission","volume":"173","author":"Pantaleo","year":"1991","journal-title":"J. Exp. Med"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1006\/jmbi.1993.1203","article-title":"Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries","volume":"230","author":"Barbas","year":"1993","journal-title":"J. Mol. Biol"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03401745","article-title":"Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein","volume":"4","author":"Bera","year":"1998","journal-title":"Mol. Med"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1006\/jmbi.1995.0626","article-title":"CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range","volume":"254","author":"Yang","year":"1995","journal-title":"J. Mol. Biol"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1073\/pnas.91.9.3809","article-title":"In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity","volume":"91","author":"Barbas","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4049\/jimmunol.154.2.893","article-title":"Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure","volume":"154","author":"Ditzel","year":"1995","journal-title":"J. Immunol"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.molimm.2006.12.005","article-title":"Antibodies to the superantigenic site of HIV-1 gp120: Hydrolytic and binding activities of the light chain subunit","volume":"44","author":"Nishiyama","year":"2007","journal-title":"Mol. Immunol"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00002030-200401230-00026","article-title":"Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library","volume":"18","author":"Karle","year":"2004","journal-title":"AIDS"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"19116","DOI":"10.1074\/jbc.M110.116699","article-title":"Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1","volume":"285","author":"Koh","year":"2010","journal-title":"J. Biol. Chem"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1128\/JVI.01379-08","article-title":"Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120","volume":"82","author":"Forsman","year":"2008","journal-title":"J. Virol"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/viro.1997.8651","article-title":"Mutant CD4 molecules with improved binding to HIV envelope protein gp120 selected by phage display","volume":"234","author":"Krykbaev","year":"1997","journal-title":"Virology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/jmbi.1996.0069","article-title":"Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: Use of phage display to improve affinity and broaden strain reactivity","volume":"256","author":"Thompson","year":"1996","journal-title":"J. Mol. Biol"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/jmbi.1997.0912","article-title":"Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries","volume":"267","author":"Ditzel","year":"1997","journal-title":"J. Mol. Biol"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1128\/JVI.73.7.5795-5802.1999","article-title":"Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries","volume":"73","author":"Ferrer","year":"1999","journal-title":"J. Virol"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1073\/pnas.102562599","article-title":"Broadly cross-reactive HIV-1-neutralizing human monoclonal fab selected for binding to gp120-CD4-CCR5 complexes","volume":"99","author":"Moulard","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1128\/JVI.00165-10","article-title":"Peptide ligands selected with cd4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage","volume":"84","author":"Dervillez","year":"2010","journal-title":"J. Virol"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"Zwick","year":"2001","journal-title":"J. Virol"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.02588-06","article-title":"An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10","volume":"81","author":"Nelson","year":"2007","journal-title":"J. Virol"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"16828","DOI":"10.1073\/pnas.0708109104","article-title":"Potent d-peptide inhibitors of HIV-1 entry","volume":"104","author":"Welch","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1128\/JVI.01339-10","article-title":"Design of a potent d-peptide HIV-1 entry inhibitor with a strong barrier to resistance","volume":"84","author":"Welch","year":"2010","journal-title":"J. Virol"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0092-8674(00)80066-5","article-title":"Inhibiting HIV-1 entry: Discovery of d-peptide inhibitors that target the gp41 coiled-coil pocket","volume":"99","author":"Eckert","year":"1999","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.0506927102","article-title":"A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope","volume":"102","author":"Miller","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.201392898","article-title":"Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region","volume":"98","author":"Eckert","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbrc.2011.09.012","article-title":"Synthetic fab fragments that bind the HIV-1 gp41 heptad repeat regions","volume":"413","author":"Liu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.febslet.2006.07.067","article-title":"Identification of the HIV-1 gp41 core-binding motif\u2014HXXNPF","volume":"580","author":"Huang","year":"2006","journal-title":"FEBS Lett"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/BJ20061275","article-title":"The mechanism by which molecules containing the HIV gp41 core-binding motif hxxnpf inhibit HIV-1 envelope glycoprotein-mediated syncytium formation","volume":"403","author":"Huang","year":"2007","journal-title":"Biochem. J"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jmb.2005.09.044","article-title":"Characterization and HIV-1 fusion inhibitory properties of monoclonal fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41","volume":"353","author":"Louis","year":"2005","journal-title":"J. Mol. Biol"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"12946","DOI":"10.1128\/JVI.01260-07","article-title":"A monoclonal fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains","volume":"81","author":"Gustchina","year":"2007","journal-title":"J. Virol"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2009.07.019","article-title":"Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal fab derived from a synthetic naive human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of fabs with improved HIV-1 neutralization potency and breadth","volume":"393","author":"Gustchina","year":"2009","journal-title":"Virology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1128\/JVI.01050-08","article-title":"Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41","volume":"82","author":"Gustchina","year":"2008","journal-title":"J. Virol"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2008.04.005","article-title":"Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics","volume":"377","author":"Nelson","year":"2008","journal-title":"Virology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1128\/JVI.00033-08","article-title":"Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens","volume":"82","author":"Zhang","year":"2008","journal-title":"J. Virol"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2007.01.015","article-title":"Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies","volume":"363","author":"Choudhry","year":"2007","journal-title":"Virology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2006.09.016","article-title":"Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning","volume":"317","author":"Zhang","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1074\/jbc.273.14.8009","article-title":"Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins","volume":"273","author":"BouHamdan","year":"1998","journal-title":"J. Biol. Chem"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/viro.2002.1765","article-title":"Antibody fragments selected by phage display against the nuclear localization signal of the HIV-1 Vpr protein inhibit nuclear import in permeabilized and intact cultured cells","volume":"305","author":"Krichevsky","year":"2003","journal-title":"Virology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1021\/bi049385e","article-title":"Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase","volume":"43","author":"Desjobert","year":"2004","journal-title":"Biochemistry"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0161-5890(95)00153-0","article-title":"Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: Direct selection from a combinatorial phage display library","volume":"33","author":"Pilkington","year":"1996","journal-title":"Mol. Immunol"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1074\/jbc.M208297200","article-title":"Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies","volume":"278","author":"Bai","year":"2003","journal-title":"J. Biol. Chem"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/rna.2.1.1681","article-title":"Selection by phage display of peptides targeting the HIV-1 Tar element","volume":"2","author":"Kolb","year":"2005","journal-title":"RNA Biol"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(95)00158-6","article-title":"Use of a constrain phage displayed-peptide library for the isolation of peptides binding to HIV-1 nucleocapsid protein (NCp7)","volume":"361","author":"Lener","year":"1995","journal-title":"FEBS Lett"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/cbic.200300681","article-title":"Identification of peptide ligands for target RNA structures derived from the HIV-1 packaging signal \u03c8 by screening phage-displayed peptide libraries","volume":"4","author":"Pustowka","year":"2003","journal-title":"ChemBioChem"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/cmdc.200700194","article-title":"Inhibition of HIV-1 by a peptide ligand of the genomic RNA packaging signal \u03c8","volume":"3","author":"Dietz","year":"2008","journal-title":"ChemMedChem"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virusres.2004.05.012","article-title":"Selection and characterization of peptides specifically binding to HIV-1 \u03a8 (\u03a8) RNA","volume":"106","author":"Park","year":"2004","journal-title":"Virus Res"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jbiosc.2010.12.025","article-title":"Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and Vif","volume":"111","author":"Yoshikawa","year":"2011","journal-title":"J. Biosci. Bioeng"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2010-07-296749","article-title":"Inhibition of the nef regulatory protein of HIV-1 by a single-domain antibody","volume":"117","author":"Bouchet","year":"2011","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/aid.2009.0036","article-title":"Short communication: Generation of recombinant monoclonal antibodies against an immunodominant HLA-A*2402-restricted HIV type 1 CTL epitope","volume":"25","author":"Nunoya","year":"2009","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1074\/jbc.M004895200","article-title":"The multimerization of human immunodeficiency virus type I Vif protein: A requirement for Vif function in the viral life cycle","volume":"276","author":"Yang","year":"2001","journal-title":"J. Biol. Chem"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1074\/jbc.M210164200","article-title":"Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins","volume":"278","author":"Yang","year":"2003","journal-title":"J. Biol. Chem"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1099\/0022-1317-82-4-813","article-title":"An immunodominant neutralization epitope on the \u201cthumb\u201d subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by phage display antibodies","volume":"82","author":"Ohba","year":"2001","journal-title":"J. Gen. Virol"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1099\/0022-1317-77-12-2921","article-title":"A novel neutralization epitope on the \u201cthumb\u201d subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody","volume":"77","author":"Chiba","year":"1996","journal-title":"J. Gen. Virol"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1570-9639(03)00118-3","article-title":"Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1","volume":"1648","author":"Herschhorn","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/jmbi.1998.2085","article-title":"HIV-1 Rev nuclear export signal binding peptides isolated by phage display","volume":"283","author":"Jensen","year":"1998","journal-title":"J. Mol. Biol"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4161\/rna.8.2.13782","article-title":"Measuring cooperative Rev protein-protein interactions on rev responsive RNA by fluorescence resonance energy transfer","volume":"8","author":"Vercruysse","year":"2011","journal-title":"RNA Biol"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"21768","DOI":"10.1074\/jbc.M110.112490","article-title":"An intrabody based on a llama single-domain antibody targeting the N-terminal \u03b1-helical multimerization domain of HIV-1 Rev prevents viral production","volume":"285","author":"Vercruysse","year":"2010","journal-title":"J. Biol. Chem"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jmb.2010.01.061","article-title":"Generation and characterization of a chimeric rabbit\/human fab for co-crystallization of HIV-1 Rev","volume":"397","author":"Stahl","year":"2010","journal-title":"J. Mol. Biol"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nsmb964","article-title":"A peptide inhibitor of HIV-1 assembly in vitro","volume":"12","author":"Sticht","year":"2005","journal-title":"Nat. Struct. Mol. Biol"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2174\/1381612033454720","article-title":"Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41","volume":"9","author":"Huang","year":"2003","journal-title":"Curr. Pharm. Des"},{"key":"ref_126","first-page":"721","article-title":"Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: An emerging opportunity for drug development","volume":"7","author":"Kadow","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2004.12.008","article-title":"Molecular characterization of the circulating anti-HIV-1 gp120-specific b cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs","volume":"297","author":"Koefoed","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(97)00043-6","article-title":"Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design","volume":"57","author":"Parren","year":"1997","journal-title":"Immunol. Lett"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/aid.1994.10.1071","article-title":"Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease","volume":"10","author":"Bermas","year":"1994","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-1759(02)00236-3","article-title":"Prospects for immunotherapeutic proteolytic antibodies","volume":"269","author":"Zhou","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"28314","DOI":"10.1074\/jbc.M102530200","article-title":"Phosphonate ester probes for proteolytic antibodies","volume":"276","author":"Paul","year":"2001","journal-title":"J. Biol. Chem"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"39611","DOI":"10.1074\/jbc.M406719200","article-title":"Naturally occurring proteolytic antibodies: Selective immunoglobulin m-catalyzed hydrolysis of HIV gp120","volume":"279","author":"Paul","year":"2004","journal-title":"J. Biol. Chem"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2005.10.003","article-title":"Theory of proteolytic antibody occurrence","volume":"103","author":"Paul","year":"2006","journal-title":"Immunol. Lett"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1006\/jmbi.1995.0580","article-title":"Site-directed mutagenesis of proteolytic antibody light chain","volume":"253","author":"Gao","year":"1995","journal-title":"J. Mol. Biol"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Atarhouch","year":"1993","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.antiviral.2011.09.002","article-title":"Nanobodies(r): New ammunition to battle viruses","volume":"92","author":"Vanlandschoot","year":"2011","journal-title":"Antiviral Res"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1021\/bi035088i","article-title":"Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions","volume":"43","author":"Biorn","year":"2004","journal-title":"Biochemistry"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.4049\/jimmunol.177.10.6579","article-title":"Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15","volume":"177","author":"Garg","year":"2006","journal-title":"J. Immunol"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbrc.2007.12.104","article-title":"The ixodes scapularis salivary protein, Salp15, prevents the association of HIV-1 gp120 and CD4","volume":"367","author":"Juncadella","year":"2008","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-3083.1999.00516.x","article-title":"Natural human antibodies retrieved by phage display libraries from healthy donors: Polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes","volume":"50","author":"Llorente","year":"1999","journal-title":"Scand. J. Immunol"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V78.1.175.175","article-title":"A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest","volume":"78","author":"Berberian","year":"1991","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/eji.1830250608","article-title":"Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B cell igM, igD and igG during HIV infection","volume":"25","author":"David","year":"1995","journal-title":"Eur. J. Immunol"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2666::AID-IMMU2666>3.0.CO;2-Q","article-title":"Molecular analysis of HIV-1 gp120 antibody response using isotype igM and igG phage display libraries from a long-term non-progressor HIV-1-infected individual","volume":"29","author":"Toran","year":"1999","journal-title":"Eur. J. Immunol"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/1521-4141(200101)31:1<128::AID-IMMU128>3.0.CO;2-T","article-title":"Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection","volume":"31","author":"Toran","year":"2001","journal-title":"Eur. J. Immunol"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/v2020547","article-title":"Cross-reactive human igm-derived monoclonal antibodies that bind to HIV-1 envelope glycoproteins","volume":"2","author":"Chen","year":"2010","journal-title":"Viruses"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.bbrc.2011.12.089","article-title":"Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens","volume":"417","author":"Chen","year":"2012","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1128\/JVI.05312-11","article-title":"Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies","volume":"85","author":"Zhu","year":"2011","journal-title":"J. Virol"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat. Rev. Drug Discov"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1126\/science.271.5257.1854","article-title":"Identification of D-peptide ligands through mirror-image phage display","volume":"271","author":"Schumacher","year":"1996","journal-title":"Science"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.1057453","article-title":"Protein design of an HIV-1 entry inhibitor","volume":"291","author":"Root","year":"2001","journal-title":"Science"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jmb.2005.03.041","article-title":"Molecular recognition by a binary code","volume":"348","author":"Fellouse","year":"2005","journal-title":"J. Mol. Biol"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nsmb1127","article-title":"Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody","volume":"13","author":"Luftig","year":"2006","journal-title":"Nat. Struct. Mol. Biol"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.73.5.4433-4438.1999","article-title":"Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: Implications for viral membrane fusion","volume":"73","author":"Lu","year":"1999","journal-title":"J. Virol"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jmbi.1999.3444","article-title":"Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and cdrs randomized with trinucleotides","volume":"296","author":"Knappik","year":"2000","journal-title":"J. Mol. Biol"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"20278","DOI":"10.1074\/jbc.M301627200","article-title":"Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion","volume":"278","author":"Louis","year":"2003","journal-title":"J. Biol. Chem"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"29485","DOI":"10.1074\/jbc.C100317200","article-title":"Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity","volume":"276","author":"Louis","year":"2001","journal-title":"J. Biol. Chem"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"14238","DOI":"10.1074\/jbc.M201453200","article-title":"Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41","volume":"277","author":"Bewley","year":"2002","journal-title":"J. Biol. Chem"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/173.1.60","article-title":"Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors","volume":"173","author":"Montefiori","year":"1996","journal-title":"J. Infect. Dis"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1006\/jmbi.1996.0485","article-title":"The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB","volume":"261","author":"Agostini","year":"1996","journal-title":"J. Mol. Biol"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/jvi.71.7.5579-5592.1997","article-title":"Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest","volume":"71","author":"Stewart","year":"1997","journal-title":"J. Virol"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1128\/jvi.64.6.3097-3099.1990","article-title":"Human immunodeficiency virus Vpr product is a virion-associated regulatory protein","volume":"64","author":"Cohen","year":"1990","journal-title":"J. Virol"},{"key":"ref_162","first-page":"11","article-title":"Identification of HIV-1 Vpr product and function","volume":"3","author":"Cohen","year":"1990","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/jvi.70.2.697-704.1996","article-title":"Human immunodeficiency virus type 1 Vpr protein binds to the Uracil DNA glycosylase DNA repair enzyme","volume":"70","author":"Bouhamdan","year":"1996","journal-title":"J. Virol"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1073\/pnas.92.8.3621","article-title":"The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product","volume":"92","author":"Refaeli","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"25564","DOI":"10.1074\/jbc.270.43.25564","article-title":"Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor sp1 and trans-activation of viral long terminal repeat","volume":"270","author":"Wang","year":"1995","journal-title":"J. Biol. Chem"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/j.1460-2075.1994.tb06308.x","article-title":"Antibody fragments from a \u201csingle pot\u201d phage display library as immunochemical reagents","volume":"13","author":"Nissim","year":"1994","journal-title":"EMBO J"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1101\/sqb.1998.63.371","article-title":"HIV-1 tat interacts with cyclin t1 to direct the p-TEFb CTD kinase complex to TAR RNA","volume":"63","author":"Garber","year":"1998","journal-title":"Cold Spring Harb. Symp. Quant. Biol"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1073\/pnas.96.9.4886","article-title":"A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity","volume":"96","author":"Druillennec","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1074\/jbc.274.16.11283","article-title":"Evidence of interactions between the nucleocapsid protein ncp7 and the reverse transcriptase of HIV-1","volume":"274","author":"Druillennec","year":"1999","journal-title":"J. Biol. Chem"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.67.1.1","article-title":"HIV-1: Fifteen proteins and an RNA","volume":"67","author":"Frankel","year":"1998","journal-title":"Annu. Rev. Biochem"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1128\/JVI.74.7.3046-3057.2000","article-title":"Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA","volume":"74","author":"Cimarelli","year":"2000","journal-title":"J. Virol"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jb\/mvg001","article-title":"Human Fc epsilon rialpha-specific human single-chain Fv (ScFv) antibody with antagonistic activity toward igE\/Fc epsilon Rialpha-binding","volume":"133","author":"Hashiguchi","year":"2003","journal-title":"J. Biochem"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1128\/jvi.70.11.7706-7712.1996","article-title":"Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family","volume":"70","author":"Gargano","year":"1996","journal-title":"J. Virol"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1073\/pnas.88.16.7366","article-title":"Human immunodeficiency virus type 1 regulator of virion expression, Rev, forms nucleoprotein filaments after binding to a purine-rich \u201cBubble\u201d Located within the Rev-responsive region of viral mRNAs","volume":"88","author":"Heaphy","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1099\/0022-1317-79-12-2883","article-title":"Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire","volume":"79","author":"Kazemier","year":"1998","journal-title":"J. Gen. Virol"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/JVI.80.5.2092-2099.2006","article-title":"Human immunodeficiency virus (HIV) vaccine trials: A novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies","volume":"80","author":"Khurana","year":"2006","journal-title":"J. Virol"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.molimm.2005.09.025","article-title":"Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling","volume":"43","author":"Vyroubalova","year":"2006","journal-title":"Mol. Immunol"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1271\/bbb.50654","article-title":"Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library","volume":"70","author":"Wang","year":"2006","journal-title":"Biosci. Biotechnol. Biochem"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/76501","article-title":"Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5","volume":"18","author":"Mirzabekov","year":"2000","journal-title":"Nat. Biotechnol"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"12575","DOI":"10.1021\/bi0492152","article-title":"Selection of active ScFv to g-protein-coupled receptor CCR5 using surface antigen-mimicking peptides","volume":"43","author":"Zhang","year":"2004","journal-title":"Biochemistry"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1111\/j.1742-4658.2011.08208.x","article-title":"Selection of a CXCR4 antagonist from a human heavy chain CDR3-derived phage library","volume":"278","author":"Chevigne","year":"2011","journal-title":"FEBS J"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1196-1240","article-title":"The role of a mutant CCR5 allele in HIV-1 transmission and disease progression","volume":"2","author":"Huang","year":"1996","journal-title":"Nat. Med"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"36073","DOI":"10.1074\/jbc.M002765200","article-title":"Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization","volume":"275","author":"Steinberger","year":"2000","journal-title":"J. Biol. Chem"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1128\/JVI.77.12.6637-6644.2003","article-title":"Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines","volume":"77","author":"Hartley","year":"2003","journal-title":"J. Virol"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"17706","DOI":"10.1073\/pnas.0805098105","article-title":"Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide","volume":"105","author":"Gaertner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"Jahnichen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/aid.2007.0215","article-title":"Identification of a strongly activating human anti-CD40 antibody that suppresses HIV type 1 infection","volume":"24","author":"Ellmark","year":"2008","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2567.2002.01473.x","article-title":"Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-coder phage display library","volume":"106","author":"Ellmark","year":"2002","journal-title":"Immunology"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Garbelli, A., Beermann, S., di Cicco, G., Dietrich, U., and Maga, G. (2011). A motif unique to the human dead-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA\/DNA unwinding and HIV-1 replication. PLoS One, 6.","DOI":"10.1371\/journal.pone.0019810"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bcp.2011.07.091","article-title":"Engineering and screening the N-terminus of chemokines for drug discovery","volume":"82","author":"Chevigne","year":"2011","journal-title":"Biochem. Pharmacol"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/14728222.9.6.1267","article-title":"The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis","volume":"9","author":"Tamamura","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2174\/138955709791012265","article-title":"Targeting CXCR4 in HIV cell-entry inhibition","volume":"9","author":"Steen","year":"2009","journal-title":"Mini Rev. Med. Chem"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.molimm.2007.09.001","article-title":"Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope","volume":"45","author":"Deroo","year":"2008","journal-title":"Mol. Immunol"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0161-5890(98)00075-3","article-title":"Anti-CD34+ fabs generated against hematopoietic stem cells in HIV-derived combinatorial immunoglobulin library suggest antigen-selected autoantibodies","volume":"35","author":"Rubinstein","year":"1998","journal-title":"Mol. Immunol"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/aid.2007.0216","article-title":"Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor use","volume":"24","author":"Abayneh","year":"2008","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.8493554","article-title":"Substrate phage: Selection of protease substrates by monovalent phage display","volume":"260","author":"Matthews","year":"1993","journal-title":"Science"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1128\/JVI.75.19.9458-9469.2001","article-title":"Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases","volume":"75","author":"Beck","year":"2001","journal-title":"J. Virol"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/viro.2000.0420","article-title":"Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development","volume":"274","author":"Beck","year":"2000","journal-title":"Virology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1021\/bi00135a008","article-title":"Kinetic and modeling studies of s3-s3\u2032 subsites of HIV proteinases","volume":"31","author":"Tozser","year":"1992","journal-title":"Biochemistry"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/228027a0","article-title":"Interferon production by t4 coliphage","volume":"228","author":"Kleinschmidt","year":"1970","journal-title":"Nature"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1586\/14760584.3.4.463","article-title":"Bacterial viruses as human vaccines?","volume":"3","author":"Clark","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.vaccine.2003.11.065","article-title":"Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle","volume":"22","author":"Jepson","year":"2004","journal-title":"Vaccine"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-1119(93)90157-X","article-title":"Design of specific immunogens using filamentous phage as the carrier","volume":"128","author":"Minenkova","year":"1993","journal-title":"Gene"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/78490","article-title":"Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses","volume":"18","author":"Sartorius","year":"2000","journal-title":"Nat. Biotechnol"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/jmbi.1994.1643","article-title":"Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120","volume":"243","author":"Willis","year":"1994","journal-title":"J. Mol. Biol"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.imlet.2004.07.011","article-title":"Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41","volume":"95","author":"Cano","year":"2004","journal-title":"Immunol. Lett"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.bmcl.2008.07.051","article-title":"Phage display of functional, full-length human and viral membrane proteins","volume":"18","author":"Majumdar","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1574-6976.1995.tb00184.x","article-title":"Engineering a peptide epitope display system on filamentous bacteriophage","volume":"17","author":"Perham","year":"1995","journal-title":"FEMS Microbiol. Rev"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0378-1119(98)00298-4","article-title":"Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid","volume":"215","author":"Ren","year":"1998","journal-title":"Gene"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jmb.2008.04.049","article-title":"Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2","volume":"380","author":"Peabody","year":"2008","journal-title":"J. Mol. Biol"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.vaccine.2011.01.038","article-title":"Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env","volume":"29","author":"Mattiacio","year":"2011","journal-title":"Vaccine"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/pro.5560050909","article-title":"Phage display of intact domains at high copy number: A system based on soc, the small outer capsid protein of bacteriophage T4","volume":"5","author":"Ren","year":"1996","journal-title":"Protein Sci"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molimm.2009.09.024","article-title":"Variable epitope library-based vaccines: Shooting moving targets","volume":"47","author":"Saavedra","year":"2009","journal-title":"Mol. Immunol"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1128\/JVI.00235-06","article-title":"Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: A novel in vitro approach to construct multicomponent HIV vaccines","volume":"80","author":"Sathaliyawala","year":"2006","journal-title":"J. Virol"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1016\/j.vaccine.2010.04.049","article-title":"Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus l2 epitope, on virus-like particles of the RNA bacteriophage PP7","volume":"28","author":"Medford","year":"2010","journal-title":"Vaccine"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1016\/j.vaccine.2011.05.007","article-title":"Variable epitope libraries: New vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response","volume":"29","author":"Viveros","year":"2011","journal-title":"Vaccine"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-2836(77)80088-0","article-title":"The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro","volume":"109","author":"Ishii","year":"1977","journal-title":"J. Mol. Biol"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature04817","article-title":"Distribution and three-dimensional structure of AIDS virus envelope spikes","volume":"441","author":"Zhu","year":"2006","journal-title":"Nature"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1386207013331309","article-title":"Antigenic and immunogenic phage displayed mimotopes as substitute antigens: Applications and limitations","volume":"4","author":"Deroo","year":"2001","journal-title":"Comb. Chem. High Throughput Screen"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/13\/4\/4727\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:48Z","timestamp":1760219388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/13\/4\/4727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,13]]},"references-count":220,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["ijms13044727"],"URL":"https:\/\/doi.org\/10.3390\/ijms13044727","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,13]]}}}